SYK |
SYK: Tyrosine-protein kinase SYK |
HLA-DRB5 |
HLA-Dw12: Cell surface glycoprotein |
21.010 |
Evidence |
|
FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
FCER1G |
FCER1G: High affinity immunoglobulin epsilon receptor subunit gamma precursor |
21.010 |
Evidence |
|
HLA-E |
HLA-E, XXbac-BPG34K20.2-001: MHC class Ib antigen |
LYN |
LYN: Tyrosine-protein kinase Lyn |
21.010 |
Evidence |
|
VAV1 |
VAV1, VAV: Proto-oncogene vav |
HLA-E |
HLA-E, XXbac-BPG34K20.2-001: MHC class Ib antigen |
21.010 |
Evidence |
|
LYN |
LYN: Tyrosine-protein kinase Lyn |
FCER1G |
FCER1G: High affinity immunoglobulin epsilon receptor subunit gamma precursor |
21.010 |
Evidence |
|
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
HLA-F |
HLA-F, HLA-5.4, HLAF: HLA class I histocompatibility antigen, alpha chain F prec |
21.010 |
Evidence |
|
LYN |
LYN: Tyrosine-protein kinase Lyn |
HLA-DRB5 |
HLA-Dw12: Cell surface glycoprotein |
21.010 |
Evidence |
|
HLA-F |
HLA-F, HLA-5.4, HLAF: HLA class I histocompatibility antigen, alpha chain F prec |
CSK |
CSK: Tyrosine-protein kinase CSK |
21.010 |
Evidence |
|
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
HMGA1 |
HMGA1, HMGIY: High mobility group protein HMG-I/HMG-Y |
20.820 |
Evidence |
|
GSN |
GSN: Gelsolin precursor |
ACTB |
ACTG1, ACTB, ACTG: Actin, cytoplasmic 2 |
20.790 |
Evidence |
|
H2AFX |
H2AFX, H2AX: Histone H2A.x |
HIST1H2BO |
HIST1H2BO, H2BFH, H2BFN: Histone H2B type 1-O |
20.790 |
Evidence |
|
H2AFX |
H2AFX, H2AX: Histone H2A.x |
HIST1H2BD |
HIST1H2BD, H2BFB, HIRIP2: Histone H2B type 1-D |
20.790 |
Evidence |
|
TCF12 |
TCF12, HEB, HTF4: Transcription factor 12 |
MYOG |
MYOG, MYF4: Myogenin |
20.780 |
Evidence |
|
MYF5 |
MYF5: Myogenic factor 5 |
TCF4 |
TCF4, ITF2, SEF2: Transcription factor 4 |
20.780 |
Evidence |
|
HLA-G |
HLA-G, HLA-6.0, HLAG: HLA class I histocompatibility antigen, alpha chain G prec |
CD1B |
CD1B: T-cell surface glycoprotein CD1b precursor |
20.780 |
Evidence |
|
CHRNB2 |
CHRNB2: Neuronal acetylcholine receptor subunit beta-2 precursor |
CHRNB4 |
CHRNB4: Neuronal acetylcholine receptor subunit beta-4 precursor |
20.780 |
Evidence |
|
ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
GRAP |
GRAP: GRB2-related adapter protein |
20.780 |
Evidence |
|
EFNA5 |
EFNA5, EPLG7, LERK7: Ephrin-A5 precursor |
CNTN2 |
CNTN2, AXT, TAG1, TAX1: Contactin-2 precursor |
20.780 |
Evidence |
|
SERPINE2 |
SERPINE2, PI7, PN1: Glia-derived nexin precursor |
HGFAC |
HGFAC: Hepatocyte growth factor activator precursor |
20.780 |
Evidence |
|
NR1D1 |
NR1D1, EAR1, HREV, THRAL: Orphan nuclear receptor NR1D1 |
HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
20.750 |
Evidence |
|
HLA-C |
HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor |
LILRB1 |
IPI00385703 |
20.750 |
Evidence |
|
HLA-G |
HLA-G, HLA-6.0, HLAG: HLA class I histocompatibility antigen, alpha chain G prec |
LILRB1 |
IPI00385703 |
20.750 |
Evidence |
|
LAMR1 |
RPSA, LAMBR, LAMR1: 40S ribosomal protein SA |
RAN |
RAN, ARA24, OK/SW-cl.81: GTP-binding nuclear protein Ran |
20.690 |
Evidence |
|
RPL3 |
RPL3, OK/SW-cl.32: 60S ribosomal protein L3 |
HNRPK |
IPI00216746 |
20.690 |
Evidence |
|
CD14 |
CD14: Monocyte differentiation antigen CD14 precursor |
LY96 |
LY96, ESOP1, MD2: Lymphocyte antigen 96 precursor |
20.670 |
Evidence |
|